Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Acta Endocrinol (Buchar) ; 13(3): 349-355, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-31149199

RESUMO

CONTEXT: Several enlarged parathyroid glands could be found during thyroid surgery in normocalcemic patients without evidence of primary or secondary hyperparathyroidism, indicating multiglandular parathyroid gland disease (MGD). OBJECTIVE: Clinical role of various levels of serum ionized calcium (Ca2+) in patients diagnosed with incidental MGD during thyroid surgery remains controversial. The aim of the study was to evaluate the features of PHPT and the clinical role of serum Ca2+ in normocalcemic patients diagnosed with incidental MGD. STUDY DESIGN: A prospective study of patients with normal preoperative Ca2+ to be operated on for thyroid diseases in 2010-2013 and diagnosed with MGD during thyroid surgery. METHODS: An analysis of clinical data from 3,561 patients to be surgically treated for thyroid diseases revealed 219 (6%) patients with MGD and normal serum Ca2+. Further data analyses showed patients with MGD and high normal (≥1.25 - 1.3 mmol/L) serum Ca2+ (n = 89) and with moderate-low (1.0 - 1.24 mmol/L) serum Ca2+ (n = 130). RESULTS: Primary hyperparathyroidism was diagnosed intra- and post-operatively in 48 (54%) patients with high-normal serum Ca2+ and in 2 (2%) patients with moderate-low serum Ca2+ (p<0.0001). Parathyroid hormone, serum Ca2+ as well as urine calcium excretion were elevated in 2 (2%) patients with moderate-low serum Ca2+ and in 18 (20%) patients with high-normal Ca2+ at follow-up (p<0.0001). CONCLUSION: Serum Ca2+ level within the normal range, but higher than 1.25 mmol/L (high-normal) is associated with primary hyperparathyroidism, which should be considered in patients with visually diagnosed MGD, but without clinical symptoms of hyperparathyroidism.

2.
Klin Khir ; (7): 5-8, 2012 Jul.
Artigo em Ucraniano | MEDLINE | ID: mdl-23033768

RESUMO

Results of surgical treatment of 93 primary patients with medullary thyroid carcinoma within 1995-2009 years, including 26 (28%) - with hereditary disease (MEN2 syndrome) were analyzed. The best long-term results were observed in group of noninvasive tumor without metastases at the time of operation (39% - clinical and biochemical recovery, 32% - clinical remission). No one patient with extrathyroid tumor invasion and regional/distant metastases has completely recovered. Hereditary forms of disease are more aggressiveness in comparison with sporadic carcinomas with higher rate of distant metastases (31 and 21%) and worse survival. In sporadic group 3 (6%) patients and in hereditary group - 4 (12%) died from progression of distant metastases within 8-15 years after primary operation. Complete recovery was seen only after radical primary operations. Repeated surgery was palliative. Implementation of calcitonine screening and genetic testing for Ret-protooncogene mutation is an important task for Ukraine medicine to improve results of medullary carcinoma treatment.


Assuntos
Carcinoma Medular/secundário , Carcinoma Medular/cirurgia , Neoplasias da Glândula Tireoide/mortalidade , Neoplasias da Glândula Tireoide/cirurgia , Adulto , Idade de Início , Idoso , Carcinoma Medular/genética , Carcinoma Medular/mortalidade , Comorbidade , Feminino , Predisposição Genética para Doença , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasia Endócrina Múltipla Tipo 2a/genética , Neoplasia Endócrina Múltipla Tipo 2a/mortalidade , Taxa de Sobrevida , Neoplasias da Glândula Tireoide/genética , Resultado do Tratamento
3.
Klin Khir ; (7): 9-11, 2012 Jul.
Artigo em Ucraniano | MEDLINE | ID: mdl-23033769

RESUMO

Incidence of unexpected diagnosis of thyroid carcinoma among operations on benign thyroid surgical diseases (nodular goiter and Graves' disease) was studied in 608 patients within 2008-2009 years in specialized clinic of endocrine surgery. In 56 (9.2%) patients the "incidental" thyroid carcinoma including 43 (77%) - papillary microcarcinoma were diagnosed in histological investigations. In 10 (18%) patients which were performed within the first postoperative week. Repeated surgery demonstrates increased risk of complication (damage of parathyroid glands, recurrent laryngeal nerves and other anatomic structures of neck) considering less favoring conditions for secondary operations, it is worth to implement wider indications to frozen section, radical primary operation (total thyroidectomy at multi-nodular bilateral goiter and Graves' disease), and also maximal complete examination prior to surgery.


Assuntos
Carcinoma Papilar/epidemiologia , Bócio Nodular/epidemiologia , Bócio Nodular/cirurgia , Doença de Graves/epidemiologia , Doença de Graves/cirurgia , Neoplasias da Glândula Tireoide/epidemiologia , Carcinoma Papilar/diagnóstico , Comorbidade , Bócio/epidemiologia , Bócio/cirurgia , Humanos , Achados Incidentais , Período Intraoperatório , Reoperação , Neoplasias da Glândula Tireoide/diagnóstico , Neoplasias da Glândula Tireoide/cirurgia
4.
Fiziol Zh (1994) ; 61(5): 21-7, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26845840

RESUMO

The levels of osteoassociated hormones, macroelements, interleukines, cyclic nucleotides and activity of alkaline phosphatase were being detected in the blood plasma of 74 postmenopausal women with and without osteoporosis (OP). Bone mineral density (BMD) and the metacarpal index were being assessed according to the results of densitometry. The allele polymorphisms vitamin D receptor gene (VDR) Cdx2 (rs11568820) and TaqI (rs731236) were being identified with the help of the polymerase chain reaction. The major genotype CC TaqI was found in the group without OP 3.4 times more often than with OP, while the minor genotype TT was found 3.4 times more often with the presence of OP. The presence of the genotype CC TaqI decreased the risk of OP progress by 5.5 times, and the genotype TT TaqI increased by 5.4 times. The presence of the minor allele T was associated with the higher levels of interleukin 1ß, BMD and lower testosterone blood level. The major homozygote AA Cdx2 was found in women without OP 2.9 times more often, while the minor genotype GG - 5.4 times more often with the presence of OP. The presence of the major homozygote decreased the risk of OP progress by more than 5.3 times, while the minor homozygote increased the risk by 8 times. The presence of the minor allele G in the genotype was associated with the increase of parathyroid hormone, phosphorus, magnesium, alkaline phosphatase activity in blood, BMD and with the decrease of testosterone, progesterone and calcium blood levels.


Assuntos
Osteoporose Pós-Menopausa/genética , Hormônio Paratireóideo/sangue , Polimorfismo de Nucleotídeo Único , Progesterona/sangue , Receptores de Calcitriol/genética , Testosterona/sangue , Fosfatase Alcalina/sangue , Alelos , Densidade Óssea , Cálcio/sangue , Estudos de Casos e Controles , Desoxirribonucleases de Sítio Específico do Tipo II/química , Feminino , Expressão Gênica , Genótipo , Heterozigoto , Homozigoto , Humanos , Interleucina-1beta/sangue , Magnésio/sangue , Pessoa de Meia-Idade , Osteoporose Pós-Menopausa/sangue , Osteoporose Pós-Menopausa/patologia , Fósforo/sangue , Reação em Cadeia da Polimerase , Polimorfismo de Fragmento de Restrição , Pós-Menopausa/sangue , Pós-Menopausa/genética , Receptores de Calcitriol/sangue
5.
Lik Sprava ; (4): 29-32, 2001.
Artigo em Ucraniano | MEDLINE | ID: mdl-11692721

RESUMO

Data are submitted from the analysis of factors of the pathogenesis of multinodular non-toxic goiter in 380 persons. Of these, 256 underwent surgery. An apparent iodine deficiency in the body (in two thirds of patients) has been found out to be an important cause of development, progression and recurrence of goiter. Only 5 to 14 percent of patients, predominantly those presenting with recurrent goiter, demonstrated an elevated level of thyrotrophin. More commonly seen in these patients is inherited predisposition to goiter. The authors attach much value to urine iodine levels, and consider it mandatory that a correction of iodine deficiency be carried off with available drugs both during the conservative treatment and in recurrences.


Assuntos
Bócio Nodular/cirurgia , Iodo/deficiência , Adolescente , Adulto , Idoso , Criança , Quimioterapia Combinada , Feminino , Predisposição Genética para Doença , Bócio Nodular/tratamento farmacológico , Humanos , Iodo/urina , Masculino , Pessoa de Meia-Idade , Iodeto de Potássio/uso terapêutico , Prevenção Secundária , Tireotropina/sangue , Tiroxina/uso terapêutico , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA